Chronic insomnia
Conditions
Interventions
Experimental Group:Brief behavioral therapy for insomnia
Sponsors
The First Affiliated Hospital of Dalian Medical University
Eligibility
Sex/Gender
All
Age
16 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 16-80 years, gender is not limited; 2. Insomnia symptoms after COVID-19 infection; 3. Meeting the Diagnostic and Statistical Manual of Mental Disorders V Edition (DSM-V) criteria for insomnia: (1) Patients complained of dissatisfaction with sleep quality or sleep duration, including inability to fall asleep, waking up early, and difficulty maintaining stable sleep (frequent awakenings at night and difficulty falling asleep after waking up); (2) Insomnia disorder leads to significant clinical symptoms or impaired social, occupational, educational, and behavioral functions; (3) The frequency of the above symptoms was more than 3 times/week; (4) The above symptoms have lasted for at least 3 months; (5) Adequate sleep opportunities and good sleep environment; (6) Complain of at least one negative daytime effect (e.g., fatigue, impaired functioning, or mood disturbance) attributable to poor sleep; (7) The above symptoms cannot be explained by other sleep-wake disorders (e.g., narcolepsy, respiratory-related sleep disorders, circadian rhythm sleep disorders, parasomnia); (8) The above symptoms are not physical effects caused by drugs or substances (e.g., drug abuse); (9) Insomnia symptoms are not secondary to a physical or psychiatric illness; 4. Able to read and understand Chinese and use electronic devices; 5. No obvious psychological stress events, no recent serious life and psychological events that interfere with sleep (except for fear of sleep); 6. Agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Currently suffering from bipolar disorder, schizophrenia, post-traumatic stress disorder and other mental disorders that affect sleep; 2. Suffering from severe intellectual disability or physical illness; 3. Pregnant or lactating women; 4. History of epilepsy or brain injury; 5. Received cognitive-behavioral therapy for insomnia; 6. Other situations not suitable for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insomnia Severity Index, ISI;The reduction in the usage of sedative-hypnotic medications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Night time sleep status;Self-Rating Depression Scale, SDS;Pittsburgh Sleep Quality Index, PSQI;Fatigue Scale-14, FS-14;The Epworth Sleeping Scale, ESS;Coronavirus Impact Scale, CIS;Self-Rating Anxiety Scale, SAS; | — |
Countries
China
Contacts
Public ContactYi Chang
The First Affiliated Hospital of Dalian Medical University
Outcome results
None listed